FDA Approved: TOPIRAMATE — Supplemental Application (Cipla USA Inc.)

View source ↗

Summary

FDA approved Cipla USA Inc.'s supplemental application for Topiramate under ANDA 079162 for the generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Migraine

Drugs mentioned

• Topiramate (generic) (Topiramate)

Snippet

SUPPL AP for TOPIRAMATE (TOPIRAMATE)